Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Buy
51
XBI Quote, Financials, Valuation and Earnings
Last price:
$92.59
Seasonality move
:
0.83%
Day range:
$90.90 - $92.10
52-week range:
$81.14 - $105.47
Dividend yield:
0.14%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
3.5M
Avg. volume:
9.9M
1-year change:
4.98%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
XBI
SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- |
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
-- | -- | -- | -- | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | -- | -- | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | -- | -- | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | -- | -- | -- | -- |
|
XHE
SPDR S&P Health Care Equipment ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
XBI
SPDR S&P Biotech ETF
|
$91.98 | -- | -- | -- | $0.00 | 0.14% | -- |
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
$96.24 | -- | -- | -- | $0.15 | 0.58% | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
$45.27 | -- | -- | -- | $0.02 | 0.27% | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
$40.89 | -- | -- | -- | $0.03 | 0.06% | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
$33.77 | -- | -- | -- | $1.17 | 3.48% | -- |
|
XHE
SPDR S&P Health Care Equipment ETF
|
$89.60 | -- | -- | -- | $0.03 | 0.04% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
XBI
SPDR S&P Biotech ETF
|
-- | 2.133 | -- | -- |
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
-- | 5.522 | -- | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | 1.996 | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | 1.936 | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | 1.876 | -- | -- |
|
XHE
SPDR S&P Health Care Equipment ETF
|
-- | 1.612 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
XBI
SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- | -- |
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
-- | -- | -- | -- | -- | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | -- | -- | -- | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | -- | -- | -- | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | -- | -- | -- | -- | -- |
|
XHE
SPDR S&P Health Care Equipment ETF
|
-- | -- | -- | -- | -- | -- |
SPDR S&P Biotech ETF vs. Competitors
-
Which has Higher Returns XBI or LABU?
Direxion Daily S&P Biotech Bull 3X Shares has a net margin of -- compared to SPDR S&P Biotech ETF's net margin of --. SPDR S&P Biotech ETF's return on equity of -- beat Direxion Daily S&P Biotech Bull 3X Shares's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XBISPDR S&P Biotech ETF-- -- -- LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- -
What do Analysts Say About XBI or LABU?
SPDR S&P Biotech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily S&P Biotech Bull 3X Shares has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Biotech ETF has higher upside potential than Direxion Daily S&P Biotech Bull 3X Shares, analysts believe SPDR S&P Biotech ETF is more attractive than Direxion Daily S&P Biotech Bull 3X Shares.
Company Buy Ratings Hold Ratings Sell Ratings XBISPDR S&P Biotech ETF0 0 0 LABUDirexion Daily S&P Biotech Bull 3X Shares0 0 0 -
Is XBI or LABU More Risky?
SPDR S&P Biotech ETF has a beta of 0.956, which suggesting that the stock is 4.394% less volatile than S&P 500. In comparison Direxion Daily S&P Biotech Bull 3X Shares has a beta of 2.860, suggesting its more volatile than the S&P 500 by 186.014%.
-
Which is a Better Dividend Stock XBI or LABU?
SPDR S&P Biotech ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0.14%. Direxion Daily S&P Biotech Bull 3X Shares offers a yield of 0.58% to investors and pays a quarterly dividend of $0.15 per share. SPDR S&P Biotech ETF pays -- of its earnings as a dividend. Direxion Daily S&P Biotech Bull 3X Shares pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XBI or LABU?
SPDR S&P Biotech ETF quarterly revenues are --, which are smaller than Direxion Daily S&P Biotech Bull 3X Shares quarterly revenues of --. SPDR S&P Biotech ETF's net income of -- is lower than Direxion Daily S&P Biotech Bull 3X Shares's net income of --. Notably, SPDR S&P Biotech ETF's price-to-earnings ratio is -- while Direxion Daily S&P Biotech Bull 3X Shares's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Biotech ETF is -- versus -- for Direxion Daily S&P Biotech Bull 3X Shares. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XBISPDR S&P Biotech ETF-- -- -- -- LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- --
-
Which has Higher Returns XBI or PSCH?
Invesco S&P SmallCap Health Care ETF has a net margin of -- compared to SPDR S&P Biotech ETF's net margin of --. SPDR S&P Biotech ETF's return on equity of -- beat Invesco S&P SmallCap Health Care ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XBISPDR S&P Biotech ETF-- -- -- PSCHInvesco S&P SmallCap Health Care ETF-- -- -- -
What do Analysts Say About XBI or PSCH?
SPDR S&P Biotech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco S&P SmallCap Health Care ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Biotech ETF has higher upside potential than Invesco S&P SmallCap Health Care ETF, analysts believe SPDR S&P Biotech ETF is more attractive than Invesco S&P SmallCap Health Care ETF.
Company Buy Ratings Hold Ratings Sell Ratings XBISPDR S&P Biotech ETF0 0 0 PSCHInvesco S&P SmallCap Health Care ETF0 0 0 -
Is XBI or PSCH More Risky?
SPDR S&P Biotech ETF has a beta of 0.956, which suggesting that the stock is 4.394% less volatile than S&P 500. In comparison Invesco S&P SmallCap Health Care ETF has a beta of 0.976, suggesting its less volatile than the S&P 500 by 2.393%.
-
Which is a Better Dividend Stock XBI or PSCH?
SPDR S&P Biotech ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0.14%. Invesco S&P SmallCap Health Care ETF offers a yield of 0.27% to investors and pays a quarterly dividend of $0.02 per share. SPDR S&P Biotech ETF pays -- of its earnings as a dividend. Invesco S&P SmallCap Health Care ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XBI or PSCH?
SPDR S&P Biotech ETF quarterly revenues are --, which are smaller than Invesco S&P SmallCap Health Care ETF quarterly revenues of --. SPDR S&P Biotech ETF's net income of -- is lower than Invesco S&P SmallCap Health Care ETF's net income of --. Notably, SPDR S&P Biotech ETF's price-to-earnings ratio is -- while Invesco S&P SmallCap Health Care ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Biotech ETF is -- versus -- for Invesco S&P SmallCap Health Care ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XBISPDR S&P Biotech ETF-- -- -- -- PSCHInvesco S&P SmallCap Health Care ETF-- -- -- --
-
Which has Higher Returns XBI or PTH?
Invesco Dorsey Wright Healthcare Momentum ETF has a net margin of -- compared to SPDR S&P Biotech ETF's net margin of --. SPDR S&P Biotech ETF's return on equity of -- beat Invesco Dorsey Wright Healthcare Momentum ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XBISPDR S&P Biotech ETF-- -- -- PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- -
What do Analysts Say About XBI or PTH?
SPDR S&P Biotech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Dorsey Wright Healthcare Momentum ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Biotech ETF has higher upside potential than Invesco Dorsey Wright Healthcare Momentum ETF, analysts believe SPDR S&P Biotech ETF is more attractive than Invesco Dorsey Wright Healthcare Momentum ETF.
Company Buy Ratings Hold Ratings Sell Ratings XBISPDR S&P Biotech ETF0 0 0 PTHInvesco Dorsey Wright Healthcare Momentum ETF0 0 0 -
Is XBI or PTH More Risky?
SPDR S&P Biotech ETF has a beta of 0.956, which suggesting that the stock is 4.394% less volatile than S&P 500. In comparison Invesco Dorsey Wright Healthcare Momentum ETF has a beta of 0.830, suggesting its less volatile than the S&P 500 by 16.97%.
-
Which is a Better Dividend Stock XBI or PTH?
SPDR S&P Biotech ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0.14%. Invesco Dorsey Wright Healthcare Momentum ETF offers a yield of 0.06% to investors and pays a quarterly dividend of $0.03 per share. SPDR S&P Biotech ETF pays -- of its earnings as a dividend. Invesco Dorsey Wright Healthcare Momentum ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XBI or PTH?
SPDR S&P Biotech ETF quarterly revenues are --, which are smaller than Invesco Dorsey Wright Healthcare Momentum ETF quarterly revenues of --. SPDR S&P Biotech ETF's net income of -- is lower than Invesco Dorsey Wright Healthcare Momentum ETF's net income of --. Notably, SPDR S&P Biotech ETF's price-to-earnings ratio is -- while Invesco Dorsey Wright Healthcare Momentum ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Biotech ETF is -- versus -- for Invesco Dorsey Wright Healthcare Momentum ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XBISPDR S&P Biotech ETF-- -- -- -- PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- --
-
Which has Higher Returns XBI or SBIO?
ALPS Medical Breakthroughs ETF has a net margin of -- compared to SPDR S&P Biotech ETF's net margin of --. SPDR S&P Biotech ETF's return on equity of -- beat ALPS Medical Breakthroughs ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XBISPDR S&P Biotech ETF-- -- -- SBIOALPS Medical Breakthroughs ETF-- -- -- -
What do Analysts Say About XBI or SBIO?
SPDR S&P Biotech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand ALPS Medical Breakthroughs ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Biotech ETF has higher upside potential than ALPS Medical Breakthroughs ETF, analysts believe SPDR S&P Biotech ETF is more attractive than ALPS Medical Breakthroughs ETF.
Company Buy Ratings Hold Ratings Sell Ratings XBISPDR S&P Biotech ETF0 0 0 SBIOALPS Medical Breakthroughs ETF0 0 0 -
Is XBI or SBIO More Risky?
SPDR S&P Biotech ETF has a beta of 0.956, which suggesting that the stock is 4.394% less volatile than S&P 500. In comparison ALPS Medical Breakthroughs ETF has a beta of 0.889, suggesting its less volatile than the S&P 500 by 11.1%.
-
Which is a Better Dividend Stock XBI or SBIO?
SPDR S&P Biotech ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0.14%. ALPS Medical Breakthroughs ETF offers a yield of 3.48% to investors and pays a quarterly dividend of $1.17 per share. SPDR S&P Biotech ETF pays -- of its earnings as a dividend. ALPS Medical Breakthroughs ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XBI or SBIO?
SPDR S&P Biotech ETF quarterly revenues are --, which are smaller than ALPS Medical Breakthroughs ETF quarterly revenues of --. SPDR S&P Biotech ETF's net income of -- is lower than ALPS Medical Breakthroughs ETF's net income of --. Notably, SPDR S&P Biotech ETF's price-to-earnings ratio is -- while ALPS Medical Breakthroughs ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Biotech ETF is -- versus -- for ALPS Medical Breakthroughs ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XBISPDR S&P Biotech ETF-- -- -- -- SBIOALPS Medical Breakthroughs ETF-- -- -- --
-
Which has Higher Returns XBI or XHE?
SPDR S&P Health Care Equipment ETF has a net margin of -- compared to SPDR S&P Biotech ETF's net margin of --. SPDR S&P Biotech ETF's return on equity of -- beat SPDR S&P Health Care Equipment ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XBISPDR S&P Biotech ETF-- -- -- XHESPDR S&P Health Care Equipment ETF-- -- -- -
What do Analysts Say About XBI or XHE?
SPDR S&P Biotech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Health Care Equipment ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Biotech ETF has higher upside potential than SPDR S&P Health Care Equipment ETF, analysts believe SPDR S&P Biotech ETF is more attractive than SPDR S&P Health Care Equipment ETF.
Company Buy Ratings Hold Ratings Sell Ratings XBISPDR S&P Biotech ETF0 0 0 XHESPDR S&P Health Care Equipment ETF0 0 0 -
Is XBI or XHE More Risky?
SPDR S&P Biotech ETF has a beta of 0.956, which suggesting that the stock is 4.394% less volatile than S&P 500. In comparison SPDR S&P Health Care Equipment ETF has a beta of 1.012, suggesting its more volatile than the S&P 500 by 1.225%.
-
Which is a Better Dividend Stock XBI or XHE?
SPDR S&P Biotech ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0.14%. SPDR S&P Health Care Equipment ETF offers a yield of 0.04% to investors and pays a quarterly dividend of $0.03 per share. SPDR S&P Biotech ETF pays -- of its earnings as a dividend. SPDR S&P Health Care Equipment ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XBI or XHE?
SPDR S&P Biotech ETF quarterly revenues are --, which are smaller than SPDR S&P Health Care Equipment ETF quarterly revenues of --. SPDR S&P Biotech ETF's net income of -- is lower than SPDR S&P Health Care Equipment ETF's net income of --. Notably, SPDR S&P Biotech ETF's price-to-earnings ratio is -- while SPDR S&P Health Care Equipment ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Biotech ETF is -- versus -- for SPDR S&P Health Care Equipment ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XBISPDR S&P Biotech ETF-- -- -- -- XHESPDR S&P Health Care Equipment ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 26
Power Solutions International [PSIX] is down 9.73% over the past day.
Buy
65
TSLL alert for Dec 26
Direxion Daily TSLA Bull 2X Shares [TSLL] is down 3.35% over the past day.
Buy
75
SMLR alert for Dec 26
Semler Scientific [SMLR] is down 1.45% over the past day.
